Related by context. All words. (Click for frequent words.) 78 prostate specific antigen 78 antigen PSA 76 PSA prostate 75 Prostate Specific Antigen PSA 73 specific antigen 70 Prostate Specific Antigen 69 serum PSA 68 specific antigen PSA 67 serum prostate 67 antigen PSA levels 66 atypical ductal hyperplasia 65 #.#ng/ml 65 thyroglobulin 65 ERCC1 64 thyroid stimulating hormone 64 PSA velocity 64 precancer 64 HER2 expression 64 ASCUS 63 Prostate specific antigen 63 MSMB 63 advanced neoplasia 63 hydroxyvitamin D levels 62 antibody titer 62 prostate cancer CaP 62 cTnI 62 PCA3 scores 62 PSA screening 62 KRAS mutation 62 carcinoembryonic antigen 61 chlamydial infection 61 HGPIN 61 HER2 overexpression 61 advanced adenoma 61 colorectal cancer 61 colorectal neoplasia 61 serum testosterone 61 cervical lesions 61 troponin T 61 cystatin C 61 aminotransferases 61 PCa 61 BRCA mutation 61 HER-2/neu 61 neoplasia PIN 61 colon tumors 61 Androgen deprivation therapy 61 elevated CRP 61 renal cell carcinomas 61 PSA nadir 61 adenoma 60 abnormal cytology 60 follicle stimulating hormone FSH 60 CIN2 + 60 pCR 60 HBsAg 60 colorectal cancer CRC 60 homocysteine concentrations 60 Inhibin B 60 intact parathyroid hormone 60 serum creatinine levels 60 urine cytology 60 grade cervical intraepithelial 60 prostate cancers 60 atypical hyperplasia 60 serum IgE 60 CIN3 + 60 precursor lesions 60 digital rectal exams 60 B7 H3 60 sarcosine 60 endometrial cancers 60 GSTP1 60 prostate biopsy 60 BRCA2 mutation carriers 60 PSADT 60 BRCA mutations 60 transferrin saturation 60 KRAS mutations 59 ovarian carcinoma 59 CIN3 59 serum calcium levels 59 prostate tumor 59 basal cell nevus syndrome 59 troponins 59 C Reactive Protein 59 reticulocytes 59 HNSCC 59 glomerular filtration rate 59 Clusterin 59 N telopeptide 59 epithelial ovarian cancer 59 advanced adenomas 59 alanine aminotransferase ALT 59 lobular carcinoma 59 prostate tissue 59 adenoma recurrence 59 EUS FNA 59 CaP 59 lactate dehydrogenase LDH 59 Ki# 59 neoplasia 59 colorectal neoplasms 59 thyroid stimulating hormone TSH 59 digital rectal examination 59 colorectal adenoma 59 testosterone supplementation 59 inhibin 58 Viral load 58 acid phosphatase PAP 58 Her2/neu 58 clusterin 58 metastatic prostate cancer 58 sFlt 1 58 serum thyroglobulin 58 nonmelanoma skin cancers 58 clinically localized prostate 58 serum ferritin 58 lactate dehydrogenase 58 microalbumin test 58 Lp PLA2 58 prostate cancer 58 c reactive protein 58 biochemical recurrence 58 HER2 gene 58 undergone radical prostatectomy 58 androgen deficiency 58 PCA3 58 atypia 58 pancreatic lung 58 colorectal pancreatic 58 HER2 amplification 58 C reactive protein 58 K ras mutations 58 eGFR 58 #ng/ml 58 tPSA 58 cTnT 58 serum phosphate 58 colorectal polyp 58 lipid lowering drugs 58 breast endometrial 58 cardiac troponin T 58 anti HBs 58 node metastases 58 EGFR protein 58 ductal breast cancer 58 immunochemical 58 clinically insignificant 57 D dimer 57 prostate adenocarcinoma 57 chlamydial 57 biochemical relapse 57 sentinel nodes 57 undergo prostate biopsy 57 NMP# 57 prostate ovarian 57 hydroxy vitamin D 57 inhibin B 57 SUVmax 57 urine albumin 57 AST ALT 57 NMP# protein 57 HbA1C 57 mesothelin 57 microsatellite instability 57 prostate carcinoma 57 cervical carcinoma 57 tHcy 57 grade squamous intraepithelial 57 HAAH 57 serum potassium 57 IgG antibody 57 premalignant lesion 57 nuchal translucency 57 serum lipid levels 57 aspartate aminotransferase AST 57 RBC folate 57 endometrial hyperplasia 57 thyroid nodules 57 differentiated thyroid 57 elevated LDL cholesterol 57 NGAL 57 transthyretin 57 glomerular filtration 57 ImmuKnow 57 ovarian breast 57 hormone therapy estrogen 57 SGPT 57 cortisol concentrations 57 malignant polyps 57 troponin 57 hypogonadal 57 asymptomatic carotid stenosis 57 deCODE BreastCancer TM 57 HER2 57 Radical prostatectomy 57 fecal occult blood 57 Cervista HPV HR 57 ovarian hormones 57 iPTH 57 prostate cancer CRPC 57 BRCA2 carriers 57 folate intake 57 prostate cancer PCa 57 plasma folate 57 protein excretion 57 adenomatous polyps 57 grade gliomas 57 serum folate concentrations 57 testicular germ cell 57 ApoB 57 precancerous cervical lesions 57 deCODE ProstateCancer TM 57 prostate walnut 57 subclinical atherosclerosis 57 BRCA1 mutations 57 TOP2A 57 lymph node metastasis 57 nonsmall cell lung cancer 57 urothelial carcinoma 57 cytologic 57 imatinib therapy 57 CD4 + cell 57 castrate resistant 57 androgen deprivation 57 abnormal cervical 56 invasive ductal 56 BRAF mutation 56 elevated homocysteine 56 microalbuminuria 56 aneuploidy 56 GnRH agonists 56 undergoing radical prostatectomy 56 ovarian cancer 56 serum calcium 56 estrogen progesterone 56 SHBG levels 56 hs CRP 56 serum urate levels 56 thyrotropin 56 BRAF mutations 56 Bone density 56 chemosensitivity 56 localized prostate cancer 56 Adjuvant chemotherapy 56 breast carcinomas 56 Homocysteine levels 56 mammographic density 56 cervical intraepithelial neoplasia 56 8 OHdG 56 intima media thickness 56 guaiac 56 seminoma 56 creatinine levels 56 invasive lobular 56 mutated K ras 56 SPINK1 56 colorectal carcinoma 56 elevated creatinine 56 malondialdehyde 56 mitochondrial toxicity 56 MSH2 56 prostate abnormalities 56 serum cortisol 56 Rectal cancer 56 endometrial carcinoma 56 WT1 56 mutated BRCA1 56 coronary calcification 56 cisplatin resistant 56 LRP5 56 hemoglobin A1C 56 Adenomas 56 albuminuria 56 preoperative PSA 56 platelet reactivity 56 CD4 counts 56 MLH1 56 invasive carcinoma 56 BRCA2 mutations 56 epithelial tumors 56 Colorectal cancer screening 56 BRCA2 gene mutation 56 serum estradiol 56 Lp PLA 2 56 adjuvant radiation 56 Estradiol 56 NSCLC tumors 56 pheochromocytomas 56 elevated serum creatinine 56 overt hypothyroidism 56 gastrointestinal stromal tumors GISTs 56 intestinal polyps 56 Epidermal Growth Factor Receptor 56 Elevated PSA 56 SHBG 56 urate levels 56 PCA3 gene 56 cTnT levels 56 EGFR expression 56 endoglin 56 MGMT gene 56 test FOBT 56 axillary lymph nodes 56 HbF 56 alanine aminotransferase 56 arterial thickening 56 eosinophil count 56 androgen suppression therapy 56 pT3 56 ELISpot 56 breast uterine 56 mediated immunity 56 radioiodine therapy 56 selenium intake 56 ovarian pancreatic 56 colorectal cancers 56 estrogen receptor ER 56 poorer prognosis 56 maternal serum 56 prophylactic mastectomies 56 serum IGF 56 pmol L 56 myeloperoxidase 56 thromboembolic disease 56 glycated hemoglobin 56 serum urate 56 abnormal Pap test 56 F2 isoprostanes 56 hepatocellular carcinomas 56 polyp recurrence 56 serum testosterone levels 56 selenium supplementation 56 bacteriuria 56 screening colonoscopy 56 thyroid peroxidase 56 sustained virological response 56 BRCA1 mutation carriers 56 testicular cancers 56 hsCRP 56 estrogen receptor progesterone receptor 56 colorectal tumors 56 tumor recurrence 56 KRAS oncogene 56 prostatic hyperplasia 56 digital rectal exam 56 cervical cytology 56 lipoprotein 56 metaplasia 56 lobular cancer 55 overexpress HER2 55 MGUS 55 GSTT1 55 ptau 55 subclinical hypothyroidism 55 HIV HCV coinfected 55 triacylglycerol concentrations 55 microalbumin 55 adjuvant radiotherapy 55 serum biomarkers 55 BRCA2 55 fecal occult 55 Routine screening 55 telomere lengths 55 prostate tumors 55 MUC1 protein 55 exhaled nitric oxide 55 RBP4 55 microvessel density 55 gastric adenocarcinoma 55 histological subtype 55 F FDG PET 55 PGDH 55 p#INK#a 55 subclinical hyperthyroidism 55 cytological 55 acute humoral rejection 55 amino acid homocysteine 55 micronuclei 55 radical prostatectomy RP 55 malignant prostate 55 euthyroid 55 estimated glomerular filtration 55 premalignant lesions 55 malignant ovarian 55 dutasteride 55 biopsies 55 pre cancerous polyps 55 hematopoietic cancers 55 HIV RNA 55 NQO1 55 AGTR1 55 pelvic ultrasound 55 breast tumors 55 metachronous 55 natriuretic peptides 55 Metastatic Prostate Cancer 55 metastatic castration resistant 55 colonic polyps 55 ductal cancer 55 fine needle aspiration 55 hydroxyvitamin D concentrations 55 serous ovarian cancer 55 contralateral breast 55 neutrophil counts 55 HER2 receptor 55 serum homocysteine 55 CIN2 55 folate concentrations 55 prostate 55 LHRH agonists 55 seminomas 55 prophylactic mastectomy 55 pancreatic adenocarcinoma 55 neutrophil count 55 apolipoprotein A1 55 PAP smear 55 HER2 positive cancers 55 lymph node metastases 55 axillary node dissection 55 neoadjuvant chemotherapy 55 hTERT 55 orchiectomy 55 dehydroepiandrosterone sulfate 55 luteinizing hormone LH 55 anti JCV antibodies 55 intravesical therapy 55 leukocyte count 55 breast carcinoma 55 malignant lesions 55 procalcitonin 55 squamous intraepithelial lesions 55 Flexi Scope 55 creatine kinase 55 faecal occult blood 55 ADPKD 55 bladder cancers 55 lipid elevations 55 CMV infection 55 alpha fetoprotein AFP 55 peritoneal cancer 55 aspartate aminotransferase 55 ABCB1 55 immunohistochemical staining 55 serum parathyroid hormone 55 methylation markers 55 intensive statin therapy 55 colorectal breast 55 progesterone receptor negative 55 ovarian tumors 55 atherogenic dyslipidemia 55 colon polyps 55 ovarian lung 55 c MYC 55 BRCA mutation carriers 55 adiponectin levels 55 resistant hormone refractory 55 imatinib Gleevec 55 EGFR mutation 55 situ LCIS 55 premalignant 55 relapsed MM 55 gastric carcinoma 55 MAGE A3 55 Immunohistochemical staining 55 glycated hemoglobin levels 55 HNPCC 55 isoprostane 55 Leydig cell 55 colorectal polyps 55 mmol liter 55 sentinel lymph node biopsy 55 salpingo oophorectomy 55 serum TSH 55 hemoglobin A1c levels 55 localized prostate 55 pelvic lymphadenectomy 55 spiral computed tomography 55 #F FDG 55 AVODART 55 Rh factor 55 operable breast cancer 55 transaminases 55 fetuin 55 pre cancerous growths 55 haematopoietic 55 colonoscopy sigmoidoscopy 55 estrogen receptor negative 55 endogenous estrogen 55 oropharyngeal cancer 55 beta carotene supplementation 55 PCNSL 55 mIU L 55 lobular breast cancer 55 varicocele 55 Pap smears mammograms 55 leukocytosis 55 K RAS 55 helical CT 55 TT genotype 55 mutant p# 55 perimenopausal women 55 underwent radical prostatectomy 55 Pap smear 55 protein albumin 54 hereditary breast cancer 54 granulocyte 54 immunohistochemical 54 serum albumin 54 HER2 protein 54 metastatic renal cell carcinoma 54 FISH fluorescence 54 BMPR2 54 grade prostatic intraepithelial 54 colonoscopy screenings 54 hydroxyvitamin D 54 malignant pleural mesothelioma 54 serum CRP 54 metastatic lesions 54 tryptase 54 Ovary removal 54 colon cancer 54 fasting triglycerides 54 oesophageal adenocarcinoma 54 serum concentrations 54 CD4s 54 rs# [002] 54 hematological parameters 54 ovarian cancers 54 bilirubin levels 54 colonoscopy flexible sigmoidoscopy 54 IGF IR 54 hormonal therapies 54 IGFBP 54 low expressors 54 axillary dissection 54 apolipoprotein B 54 colorectal adenomas 54 colorectal carcinomas 54 naturally occurring estrogen 54 pre cancerous 54 noncancerous prostate 54 lung metastasis 54 nmol liter 54 latent tuberculosis infection 54 adenoma detection 54 IgG antibodies 54 human chorionic gonadotropin hCG 54 DHEAS 54 germline mutations 54 HER2/neu 54 precancerous cervical 54 plasma selenium 54 aberrant crypt foci 54 neoplasias 54 PIK3CA 54 mIU ml 54 oophorectomy 54 androgen independent 54 GISTs 54 FGFR2 54 hormone deprivation 54 FDG-PET/CT 54 PSA kinetics 54 TGFBR1 * 6A 54 serologic 54 QuantiFERON 54 ductal lobular 54 postoperative mortality 54 creatinine 54 estrogen progestin therapy 54 VEGF expression 54 RASSF1A 54 anti Mullerian hormone 54 K#N 54 recurrent UTI 54 sDNA 54 albumin excretion 54 colorectal cancer incidence 54 abnormal mammogram 54 USPSTF recommends 54 thyroid hormone levels 54 Haptoglobin 54 HBV infection 54 histopathologic examination 54 urinary oxalate 54 GPx 54 estrogen metabolites 54 transrectal ultrasound guided 54 transaminase levels 54 Cotinine 54 CYP#C# [001] 54 cardiac troponin 54 radiosensitivity 54 nonmetastatic 54 Digital Mammographic Imaging 54 transvaginal ultrasound 54 follicle stimulating hormone 54 androgen deprivation therapy 54 soluble endoglin 54 micrometastases 54 MammaPrint R 54 nonmelanoma skin cancer 54 multivariable analysis 54 androgens 54 antibody titers 54 mucinous 54 HPV# 54 prostate biopsies 54 lymphocytosis 54 CVD mortality 54 colorectal cancer screening 54 breast cancers 54 virologic responses 54 precancers 54 plasma lipid 54 R0 resection 54 proteinuria 54 IgA deficiency 54 SGOT 54 lupus anticoagulant 54 endometrial 54 NT proBNP 54 benign polyps 54 axillary lymph node 54 BRCA1 BRCA2 54 Oxidized LDL 54 telomerase activation 54 VKORC1 54 FDG PET 54 carotid intima media 54 FGFR1 54 elevated LDH 54 hormone receptor status 54 vaginal lesions 54 nonfasting 54 interleukin IL -# 54 LTBI 54 PKCi 54 lipoprotein Lp 54 preoperative chemotherapy 54 detecting colorectal cancer 54 SETDB1 54 PTPN# 54 distant metastasis 54 serum glucose 54 coronary artery calcium 54 paraprotein 54 CT coronary angiography 54 oestradiol 54 UGT#A# * 54 TMPRSS2 ERG 54 Carcinoid tumors 54 Septin9 54 glycosylated hemoglobin HbA1c 54 Serum creatinine 54 armpit lymph nodes 54 immunochemical fecal occult 54 undetectable PSA 54 metastatic colorectal 54 thyrotropin levels 54 homocysteine levels 54 glycated hemoglobin HbA1c 54 invasive coronary angiography 54 Pap test 54 Papillary 54 recurrent prostate cancer 54 risk HPV genotypes 54 anal cancers 54 SLNB 54 p# mutation 54 familial ALS 54 nonfasting triglycerides 54 invasive lobular carcinoma 54 lymphadenectomy 54 aminotransferase levels 54 kidney allograft 54 distal colon cancer 54 NAT2 54 genes BRCA1 54 transgene expression 54 peptide BNP 54 Invasive Breast Cancer 54 adenomas 54 familial pancreatic cancer 54 PlGF 54 Homocysteine 54 NP CRNs 54 precancerous tumors 54 BRCA2 mutation 54 nodal metastasis 54 Hemoccult II 54 Menopausal hormone therapy 54 neuroblastoma tumors 54 CK MB 54 Fecal occult blood 54 pg ml 54 Benign prostatic hyperplasia BPH 54 metastatic prostate 54 CLL cells 54 alpha defensins 54 Recurrence Score 54 clinico pathological 54 malignant nodules 54 triiodothyronine 54 BRCA1 54 mRCC 54 core needle biopsies 54 alkylating agents 54 FOLFOX6 54 cells multiply uncontrollably 54 hereditary hemochromatosis 54 Prognostic 54 latent TB infection 54 polycystic ovary syndrome PCOS 54 albumin protein 54 intravenous bisphosphonates 54 bowel cancers 54 TIMP 1 53 colorectal screening 53 soluble CD# ligand 53 neoadjuvant therapy 53 radical retropubic prostatectomy 53 basal cell carcinomas 53 metastatic malignant 53 olaparib 53 flutamide 53 benign breast 53 blood urea nitrogen 53 CHD mortality 53 Cholangiocarcinoma 53 postmenopausal breast cancer 53 inflammatory biomarkers 53 BRCA deficient 53 vulvar intraepithelial neoplasia 53 gastrointestinal cancers 53 colon rectal 53 deCODE BreastCancer 53 Squamous 53 dysglycemia 53 micrometastasis 53 adjuvant chemotherapy 53 serum HBV DNA 53 OGG1 53 basal cell 53 BRAF V#E mutation 53 cervical breast 53 paricalcitol 53 resistin 53 Doxil ® 53 serum selenium 53 TNFalpha 53 Hurthle cell 53 cytoreductive nephrectomy 53 Gram stain 53 FeNO 53 alpha fetoprotein 53 osteopenic 53 diabetic kidney 53 osteoblast 53 hemoglobin A1c 53 familial adenomatous polyposis 53 HBV DNA 53 hormone receptor negative 53 hemoglobin hematocrit 53 Prostate Lung Colorectal 53 PITX2 53 fFN 53 p# activation 53 plasma homocysteine 53 thickness IMT 53 VZV 53 Her2 53 thrombophilia 53 immunohistochemical analysis 53 malondialdehyde MDA 53 methylmalonic acid 53 Amniocentesis 53 ApoA1 53 recurrent ovarian cancer 53 biochemical marker 53 surgical biopsy 53 prostates removed 53 gastrointestinal stromal tumor GIST 53 mammographic 53 plasma pharmacokinetics 53 aminotransferase ALT 53 bcr abl 53 SCr 53 surgically resectable 53 VerifyNow 53 CYP#A# [002] 53 prostate colorectal 53 antiphospholipid antibodies 53 LVNC 53 abnormal mammograms 53 ovarian 53 galectin 3 53 tuberculin skin testing 53 Endometrial 53 EGFR mutations 53 hCG Beta 53 lymphocyte count 53 pre eclamptic 53 MCF7 53 pre cancerous lesions 53 sitosterol 53 nutlin 3a 53 PSA 53 bowel polyps 53 CD#c 53 urine NGAL 53 epithelial ovarian 53 luteinising hormone 53 PTEN gene 53 curative resection 53 testicular tumors 53 gestational hypertension 53 unresectable tumors 53 melanoma tumors 53 postoperative morbidity 53 MUC1 53 rheumatoid factor 53 prostate pancreatic 53 fasting insulin 53 ovarian endometrial 53 androgen dependent 53 promoter methylation 53 nanomolar 53 hormonal therapy 53 carotid stenosis 53 PSA Prostate Specific 53 anti androgen 53 abdominal adiposity 53 pelvic malignancies 53 μg dL 53 nestin 53 stage IIIB 53 lung carcinomas 53 Immunohistochemistry 53 narcolepsy cataplexy 53 castration resistant prostate cancer 53 histologic subtype 53 malignant transformation 53 endometrial thickness 53 breast ovarian 53 trastuzumab Herceptin 53 cyclin E 53 lymphocyte counts 53 RRM1 53 elevated triglyceride levels 53 androgenic hormones 53 APTIMA HPV 53 serum phosphorous 53 Triglyceride levels 53 nonfasting triglyceride levels 53 precancerous condition 53 circulating EPCs 53 postoperative chemotherapy 53 hormone therapy HT 53 vimentin 53 BRCA gene mutations 53 bezafibrate 53 cutaneous melanoma 53 trastuzumab Herceptin ® 53 carotid IMT 53 HG PIN 53 cytoreduction 53 flavopiridol 53 cabazitaxel 53 CD# upregulation 53 leukocyte 53 thyroxine 53 endoxifen 53 hemoglobin A1c HbA1c 53 CMV disease 53 nephrogenic 53 HOMA IR 53 elevated hsCRP 53 recurrent VTE 53 TIMP 53 SCIg 53 Zolinza 53 leukaemias 53 varicoceles 53 adnexal mass 53 male hormones androgens 53 Cystatin C 53 serum clusterin levels 53 EGFR receptor 53 squamous cell carcinoma SCC 53 underarm lymph nodes 53 thyroxine T4 53 sentinel node biopsy 53 prostate TURP 53 bronchoalveolar lavage 53 bioavailable testosterone 53 adrenal function 53 HBV DNA levels 53 MYH9 gene 53 rs# [001] 53 SLN biopsy 53 skeletal metastases 53 adiponectin 53 Akt activation 53 natriuretic peptide 53 endometrial tumors 53 HbA 1c 53 IgA 53 arterial oxygen saturation 53 squamous 53 HER2 positive breast cancer 53 HbA 1c levels 53 APOL1 53 adenocarcinomas 53 angiotensin converting enzyme 53 bladder carcinoma 53 elevated ALT 53 fluvastatin 53 CD4 cells 53 HSCT 53 uric acid levels 53 oral squamous cell 53 androgen ablation 53 alkaline phosphatase 53 postmenopausal hormone replacement 53 finasteride Proscar 53 CC genotype 53 ductal carcinomas 53 catheter angiography 53 TP# mutations 53 beta blocker therapy 53 mRNA expression 53 invasive carcinomas 53 leiomyomas 53 mesotheliomas 53 noncancer 53 excisional biopsy 53 Colon polyps 53 abnormal Pap 53 HER2 receptors 53 azacytidine 53 hypermethylated 53 chronic prostatitis 53 Darapladib 53 resected pancreatic cancer 53 autoantibodies 53 gastric cardia 53 E selectin 53 Screening Trial DMIST 53 HER2 positivity 53 undetectable HBV DNA 53 mL/min/#.# m 2 53 gemcitabine Gemzar 53 sUA 53 orchitis 53 mU L 53 Getzenberg 53 plasma homocysteine levels 52 non squamous NSCLC 52 latent tuberculosis TB 52 coronary calcium 52 preserved ejection fraction 52 cholesterol LDL C 52 serum folate 52 Li Fraumeni 52 Skin sterol 52 FLT3 52 EGF receptors 52 poor metabolizers 52 hsCRP levels 52 calculated creatinine clearance 52 bladder tumors 52 serum uric acid 52 Cyclooxygenase 2 52 prolactin levels 52 K ras 52 virologic failure 52 recurrent ovarian 52 mm ³ 52 hamartomas 52 monocyte chemoattractant protein 52 Sjögren syndrome 52 ADAMTS# 52 human leukocyte antigens 52 FGFR2 gene 52 metastatic androgen independent 52 metastatic malignant melanoma 52 pT2 52 serum IgG 52 ng dL 52 obstructive coronary artery 52 B type natriuretic 52 cytologic examination 52 colon cancer screening 52 frequent ejaculations 52 HPV 52 peripheral blood mononuclear